In August 2023, the Food and Drug Administration issued two draft guidance, both related to the development of biosimilar products, entitled “Formal Meetings between the FDA and Sponsors or Applicants ...
The basic requirements for classification systems for stillbirth are to record the underlying cause of death and other relevant information to aid in understanding of the true contributors to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results